After successfully constructing and validating DC-STAMP knockdown and overexpression THP-1 cell models, we performed phenotypic assays including CCK-8 and flow cytometry to verify the GSEA results and investigate DC-STAMP’s effects on AML cell proliferation and survival. The gene discussed is DCX; the disease is acute myeloid leukemia.